Pharmaceutical Technology

OCTOBER 20, 2024

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

Trials 130

Trials 130

FDA Law Blog

OCTOBER 20, 2024

By Larry K. Houck — Eric Idle, as a body collector, immortalized the phrase, “Bring out your dead! Bring out your dead!” in the 1975 comedy classic, Monty Python and the Holy Grail. The Drug Enforcement Administration (“DEA”) would do well to update that phrase as “Bring out your meds! Bring out your meds!” to call attention to the 26th National Prescription Take Back Day.

Drugs 59

Drugs Medicine 59

pharmaphorum

OCTOBER 20, 2024

At its second attempt, Astellas won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for claudin 18.

FDA Approval 68

FDA Approval Drugs 68

JAMA Internal Medicine

OCTOBER 20, 2024

This randomized clinical trial evaluates the effect of a patient/caregiver and prescriber-mailed educational intervention on potentially inappropriate prescribing to patients with Alzheimer disease or Alzheimer disease–related dementias.

Clinical Trials 49

Clinical Trials Clinical Trials Trials 49

Speaker: Simran Kaur, Founder & CEO at Tattva Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine